1887

n Cardiovascular Journal of Africa - Stroke prevention in non-valvular atrial fibrillation with rivaroxaban : advertorial

USD

 

Abstract

The new oral anticoagulants are the way of the future when it comes to stroke prevention in atrial fibrillation (AF). The ROCKET-AF trial showed that not only was rivaroxaban non-inferior to warfarin for preventing stroke and systemic embolism, but safer too.

Loading

Article metrics loading...

/content/cardio1/25/4/EJC157320
2014-07-01
2016-12-04
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error